209 related articles for article (PubMed ID: 16886649)
1. Role of surgery in treatment of locally advanced prostate cancer.
Prezioso D; Galasso R; Di Martino M; Iapicca G; Iacono F
Anticancer Res; 2006; 26(4B):3151-8. PubMed ID: 16886649
[TBL] [Abstract][Full Text] [Related]
2. [The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].
van den Ouden D; Schröder FH
Tijdschr Gerontol Geriatr; 1998 Apr; 29(2):74-9. PubMed ID: 9615377
[TBL] [Abstract][Full Text] [Related]
3. [Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up].
Isorna Martínez de la Riva S; Belón López-Tomasety J; Marrero Domínguez R; Alvarez Cruz E; Santamaría Blanco P
Arch Esp Urol; 2004 Sep; 57(7):679-92. PubMed ID: 15536949
[TBL] [Abstract][Full Text] [Related]
4. [Radical surgery of locally advanced prostatic cancer].
Pesqueira D; Pereiro M; Rivas C; Comesaña E; Zungri E
Actas Urol Esp; 1995; 19(7):549-54. PubMed ID: 8815666
[TBL] [Abstract][Full Text] [Related]
5. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis.
Gerber GS; Thisted RA; Chodak GW; Schroder FH; Frohmuller HG; Scardino PT; Paulson DF; Middleton AW; Rukstalis DB; Smith JA; Ohori M; Theiss M; Schellhammer PF
Eur Urol; 1997; 32(4):385-90. PubMed ID: 9412793
[TBL] [Abstract][Full Text] [Related]
6. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
[TBL] [Abstract][Full Text] [Related]
7. [The role of radical prostatectomy in cT3 prostate carcinoma].
Van Poppel H; Goethuys H; Callewaert P; Vanuytsel L; Van de Voorde W; Baert L
Praxis (Bern 1994); 2001 Sep; 90(38):1623-31. PubMed ID: 11675915
[TBL] [Abstract][Full Text] [Related]
8. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer.
Loeb S; Smith ND; Roehl KA; Catalona WJ
Urology; 2007 Jun; 69(6):1170-5. PubMed ID: 17572209
[TBL] [Abstract][Full Text] [Related]
9. [Locally advanced prostate cancer: definition, prognosis and treatment].
Plantade A; Massard C; de Crevoisier R; Fizazi K
Bull Cancer; 2007 Jul; 94(7 Suppl):F50-61. PubMed ID: 17845994
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
11. An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer.
Van Poppel H; Joniau S
Eur Urol; 2008 Feb; 53(2):253-9. PubMed ID: 17949893
[TBL] [Abstract][Full Text] [Related]
12. Is radical prostatectomy feasible in all cases of locally advanced non-bone metastatic prostate cancer? Results of a single-institution study.
Gontero P; Marchioro G; Pisani R; Zaramella S; Sogni F; Kocjancic E; Mondaini N; Bonvini D; Tizzani A; Frea B
Eur Urol; 2007 Apr; 51(4):922-9; discussion 929-30. PubMed ID: 17049718
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy for clinical stage T3a disease.
Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
[TBL] [Abstract][Full Text] [Related]
14. Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate.
Amling CL; Leibovich BC; Lerner SE; Bergstralh EJ; Blute ML; Myers RP; Zincke H
Semin Urol Oncol; 1997 Nov; 15(4):215-21. PubMed ID: 9421448
[TBL] [Abstract][Full Text] [Related]
15. Management of locally advanced prostate cancer: a European consensus.
Boccon-Gibod L; Bertaccini A; Bono AV; Dev Sarmah B; Höltl W; Mottet N; Tunn U; Zamboglou N
Int J Clin Pract; 2003 Apr; 57(3):187-94. PubMed ID: 12723722
[TBL] [Abstract][Full Text] [Related]
16. [Treatment for locally advanced prostate cancer: value of surgery].
Azuma H; Katsuoka Y
Hinyokika Kiyo; 2006 Jun; 52(6):459-67. PubMed ID: 16848360
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
[TBL] [Abstract][Full Text] [Related]
18. [Current value of seminal vesicle biopsy in patients with prostate cancer and influence of radical prostatectomy in patients with seminal vesicle invasion].
Losa CA; Fernando AB; Lázaro VA; Berlanga FF; Frago PS; López MA; Sanz MJ; Martínez PG; Sanz LA
Arch Esp Urol; 2006 Dec; 59(10):977-88. PubMed ID: 17283711
[TBL] [Abstract][Full Text] [Related]
19. [Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer].
Xylinas E; Misraï V; Comperat E; Renard-Penna R; Vaessen C; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
Prog Urol; 2009 May; 19(5):285-90. PubMed ID: 19393531
[TBL] [Abstract][Full Text] [Related]
20. A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes?
Thong AE; Shikanov S; Katz MH; Gofrit ON; Eggener S; Zagaja GP; Shalhav AL; Zorn KC
J Urol; 2008 Dec; 180(6):2436-40. PubMed ID: 18930486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
